Loading viewer...
earnings
Format: PDF earnings
Creo Medical Group plc presents FY2023 financial results and FY2024 outlook, highlighting total sales of £30.8m and 2.5x revenue increase from Speedboat Inject and CROMA products. The company achieved 49.6% gross margin and reduced underlying operating losses, with strong Q1-24 trading and growing consumables sales supporting continued growth plans.
earnings
35 Pages
Cornerstone OnDemand
Tyson Foods Q1 2024 Earnings Presentation
earningsearnings
22 Pages
Tyson Foods, Inc.